Trial Profile

Examination on change of gastric emptying ability by acid secretion suppression

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 04 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vonoprazan (Primary)
Indications Duodenal cancer; Erosive oesophagitis; Gastric cancer; Gastro-oesophageal reflux; Helicobacter infections; Peptic ulcer; Reflux oesophagitis
Focus Pharmacokinetics

Most Recent Events

23 Jun 2021 Status changed from active, no longer recruiting to completed.
23 May 2021 Results assessing gastric emptying in asymptomatic healthy subjects before and after administration of gastric acid-secreting drugs by using the T max of the 13C breath test gastric emptying test presented at the Digestive Disease Week 2021
21 Jul 2020 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com